Table 3.
Specific drug | UHS | GAIN | Meta analysisP |
||||||
---|---|---|---|---|---|---|---|---|---|
N, cases |
N, controls |
P | OR (95% CI)a | N, cases |
N, controls |
P | OR (95% CI)b | ||
Heroin and other opioids |
1,294 | 1,725 | 1.05×10−5 | 0.70 (0.60–0.82) | 113 | 496 | 0.16 | 0.70 (0.43–1.16) | 4.48×10−6 |
Cocaine | 870 | 1,725 | 1.50×10−4 | 0.71 (0.59–0.85) | 112 | 496 | 0.13 | 0.67 (0.40–1.12) | 4.58×10−5 |
Marijuana | 35 | 1,725 | 0.78 | 0.91 (0.46–1.81) | 212 | 496 | 0.0010 | 0.47 (0.30–0.74) | 0.046 |
Amphetamines and other stimulants |
113 | 1,725 | 0.12 | 0.71 (0.45–1.10) | 48 | 496 | 0.83 | 0.83 (0.43–1.63) | 1.16×10−5 |
CI, confidence interval; OR, odds ratio
Models were adjusted for sex and eigenvectors.
Models were adjusted for sex, eigenvectors, alcohol abuse and nicotine dependence.